E-LIB Suche - Ergebnisse für: Moore, Mary P.

1

Low MBOAT7 expression, a genetic risk for MASH, promotes a ..:

Moore, Mary P. ; Wang, Xiaobo ; Kennelly, John Paul...
Hepatology. , 2024

Link: https://doi.org/10.1097/..

2

Efferocytosis in liver disease:

Shi, Hongxue ; Moore, Mary P. ; Wang, Xiaobo.
JHEP Reports. 6 (2024) 1 - p. 100960 , 2024

Link: https://doi.org/10.1016/..

3

Histological improvements following energy restriction and ..:

Mucinski, Justine M. ; Salvador, Amadeo F. ; Moore, Mary P....
Journal of Hepatology. , 2024

Link: https://doi.org/10.1016/..

4

Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in ..:

Wang, Xiaobo ; Moore, Mary P. ; Shi, Hongxue...
Molecular Therapy - Methods & Clinical Development. 31 (2023) - p. 101165 , 2023

Link: https://doi.org/10.1016/..

5

Hepatocyte‐specific eNOS deletion impairs exercise‐induced ..:

Cunningham, Rory P. ; Moore, Mary P. ; Dashek, Ryan J....
Obesity. 30 (2022) 5 - p. 1066-1078 , 2022

Link: https://doi.org/10.1002/..

6

Compromised hepatic mitochondrial fatty acid oxidation and ..:

Moore, Mary P. ; Cunningham, Rory P. ; Meers, Grace M....
Hepatology. 76 (2022) 5 - p. 1452-1465 , 2022

Link: https://doi.org/10.1002/..

7

The impact of time‐restricted feeding in combination with a..:

Moore, Mary P. ; Wieschhaus, Nicole E. ; Alessi, Isabella G.
The Journal of Physiology. 600 (2022) 10 - p. 2277-2278 , 2022

Link: https://doi.org/10.1113/..

8

A Fad too Far? Dietary Strategies for the Prevention and Tr..:

Moore, Mary P. ; Cunningham, Rory P. ; Dashek, Ryan J...
Obesity. 28 (2020) 10 - p. 1843-1852 , 2020

Link: https://doi.org/10.1002/..

9

Impact of nicotinamide riboside supplementation on skeletal..:

Moore, Mary P. ; Mucinski, Justine M.
The Journal of Physiology. 598 (2020) 16 - p. 3327-3328 , 2020

Link: https://doi.org/10.1113/..

10

Hepatocyte‐Specific Deletion of eNOS Impairs Mitochondrial ..:

Cunningham, Rory P. ; Moore, Mary P. ; Meers, Grace M....
The FASEB Journal. 33 (2019) S1 - p. , 2019

Link: https://doi.org/10.1096/..

11

Hepatic Knockdown of RECK Increases NASH Susceptibility:

Cunningham, Rory P. ; Moore, Mary P. ; Nguyen, Nhu...
The FASEB Journal. 33 (2019) S1 - p. , 2019

Link: https://doi.org/10.1096/..

12

Ketogenic diet in combination with voluntary exercise impac..:

Moore, Mary P ; Cunningham, Rory P ; Kelty, Taylor J...
The FASEB Journal. 33 (2019) S1 - p. , 2019

Link: https://doi.org/10.1096/..

13

Curcumin supplementation mitigates NASH development and pro..:

Cunningham, Rory P. ; Moore, Mary P. ; Moore, Angelique N....
Physiological Reports. 6 (2018) 14 - p. e13789 , 2018

Link: https://doi.org/10.14814..

14

Dalteparin as Periprocedure Anticoagulation for Patients on..:

Tinmouth, Alan H ; Morrow, Beverley H ; Cruickshank, Moira K..
Annals of Pharmacotherapy. 35 (2001) 6 - p. 669-674 , 2001

Link: https://doi.org/10.1345/..

15

Efferocytosis in liver disease:

Shi, Hongxue ; Moore, Mary P ; Wang, Xiaobo.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10792655/. , 2023

Link: http://www.ncbi.nlm.nih...